Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets
Made For
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets
Ashpool has identified 5 products used by Blueprint Medicines
Ashpool has identified the primary mail recipient on this domain as Mimecast
Format | Success Rate |
flast@blueprintmedicines.com |
|
firstl@blueprintmedicines.com |
|